#OncTwitter
Please bookmark & share the 🧵 from the beginning to help others recognize #melanoma & the importance of early diagnosis. May #JimmyCarter rest in peace after an incredible life of service, & may we all be inspired by his example. Each of us has something to offer. #melsm #MedTwitter #OncTwitter
December 29, 2024 at 11:05 PM
November 12, 2024 at 12:53 AM
If you lack regular access to healthcare, there are free skin cancer screenings around the 🇺🇸 a few times a year, usually in warmer months. Check your state here or sign up for alerts when one will occur in your area: www.aad.org/public/publi...

/5

#melsm #MedTwitter #OncTwitter
https://aad.org/public/public-…
December 29, 2024 at 10:57 PM
Just donated to World Central Kitchen on behalf of our #HCWvsHunger Team #DiagnoseAndTreats with condolences on the tragic deaths of their aid workers today. Consider a donation to WCK, #MedSky. Visit hcwvshunger.org/faqs/ for more info on how to participate.

#OncTwitter @oncoalert.bsky.social
a candle is lit up in the dark and the flame is visible
ALT: a candle is lit up in the dark and the flame is visible
media.tenor.com
November 30, 2024 at 9:43 PM
Doing both until more #OncTwitter and #bcsm move here
November 10, 2024 at 2:12 AM
Also @n8pennell.bsky.social is here in #OncTwitter, @drawstickpeople.bsky.social. Didn’t see Nate in your replies yet. #MedSky
November 12, 2024 at 12:57 AM
New here — always in search of a challenge and blue skies. Loved the #MedTwitter/#OncTwitter community and hoping the #MedBlueSkies community will be just as good!
November 11, 2024 at 2:50 AM
Looking forward to connecting with the #bcsm #OncTwitter community & people on this platform!
September 24, 2023 at 4:12 PM
#ThreeGoodThings:
1️⃣ 4/4 #radonc in my family donated this year to #HCWvsHunger for our #oncTwitter team
2️⃣ my 🍎order arrived just in time for our last day
3️⃣ honored to run #DiagnoseAndTreats with Drs @kemimdrad.bsky.social @tmprowell.bsky.social @rovingatuscap.bsky.social
@01sth02.bsky.social 🙏
December 3, 2025 at 3:47 AM
a flock of seagulls flying through a blue sky
ALT: a flock of seagulls flying through a blue sky
media.tenor.com
November 19, 2024 at 2:48 AM
#TumorBoardTuesday

🧠And while we finalize the case details, collect FREE #CME

👉🏽http://integrityce.com/TBT2024 #OncTwitter
December 9, 2024 at 3:48 PM
Our CMO @jrgralow.bsky.social discusses each of the 5 Plenary abstracts before they're presented later today at #ASCO25 in this exclusive set of First Look videos from #ASCODailyNews: brnw.ch/21wT4xP #OncTwitter
June 1, 2025 at 12:18 PM
#SABCS24 #bcsm #OncTwitter

COMET trial published concurrently @jama.com:
ja.ma/3Zx8hiL

With accompanying editorial (see 📸): jamanetwork.com/journals/jam...

@oncoalert.bsky.social

/3
December 12, 2024 at 11:49 PM
If you haven't listened to the #ASCO25 Top Takeaways series from #ASCODailyNews, now's the time! Every day of the Meeting, Dr. John Sweetenham offers a brief podcast analysis of several key abstracts. Catch up now: brnw.ch/21wT5NC 🎧 #OncTwitter
June 2, 2025 at 2:04 PM
Attention early-career oncologists! There's still time to apply for the @ConquerCancerFd YIA in Primary Brain Tumors. This mentored award supports your transition from fellowship to faculty.

Apply by March 12th: https://bit.ly/4rhR8pn
#OncTwitter #ResearchFunding
January 30, 2026 at 3:05 PM
Now enrolling! Dr. Gabriel Brooks of Dartmouth Cancer leads the PAGODA trial (A232402CD) aimed at reducing unplanned treatment delays in people with gastrointestinal cancers. Learn more at https://bit.ly/PAGODA26. #ColorectalCancer #OncTwitter #gism #MedTwitter #ClinicalTrials
June 3, 2026 at 11:20 AM
1/29 #TumorBoardTuesday #OncTwitter

⭐️Case 1⭐️
55 yo 👩 never 🚬 p/w hemoptysis
CT shows 6x6x9 cm LLL mass 🫁
Bronchoscopy➡️ lung adeno, N2+
EGFR L878R on mol testing🧬
December 11, 2024 at 1:07 AM
Congrats to Dr. Oladayo Oyebanji for winning an ASH Abstract Achievement Award! His study of 13k+ patients shows that Medicaid expansion significantly improved survival rates for CML patients across all demographics.

Read his latest in @JAMANetworkOpen!

#MedEd #HealthEquity #OncTwitter
February 9, 2026 at 7:22 PM
✨ Day 3 at #ASCO26 has been incredible!

A big thank you to everyone who visited the ONCOassist Booth 10095 and connected with us throughout the day 🤝

Looking forward to seeing everyone on Day 4!

#OncoNews #OncoAlert #OncTwitter #OncEd #Chicago
June 1, 2026 at 5:00 AM
#SABCS24 #bcsm #OncTwitter #MedEd

In contrast, if a replacement trial shows superiority, a smaller PFS benefit may be meaningful, especially if there is another advantage such as more favorable toxicity profile, greater patient convenience, etc.

@oncoalert.bsky.social

HOWEVER…
a man in a striped shirt with the words one more little thing behind him
ALT: a man in a striped shirt with the words one more little thing behind him
media.tenor.com
December 11, 2024 at 4:08 PM
Me too! #OncTwitter and #bcsm are the only things keeping me “over there” at the moment.
November 10, 2024 at 5:46 PM
🚨🚨🚨PSA from Dr. Prowell @tmprowell.bsky.social

"Resharing this thread about how to recognize #melanoma because it’s summer. Several states have free #skincancer screenings going on now. See full thread for link to check if your state..."

PSA from Dec 2024:
threadreaderapp.com/thread/18734...
August 24, 2025 at 2:28 AM
Abstracts for #GI26 now available! Discover emerging treatment modalities, the latest clinical trial results, advances in precision medicine, and more—all in the field of gastrointestinal cancers. #gicsm #OncTwitter

View the abstracts: brnw.ch/21wYQVs
January 5, 2026 at 10:38 PM
Systemic #HRT increases #breastcancer recurrence risk by 80% in HR+ patients (HR 1.8), while HR- patients show no significant increase (HR 1.19). Shared decision-making is essential. 🩺

Read the review: https://bit.ly/3QkAJTS

#BCSM #MedEd #OncTwitter #ClinicalTrials
What Are the Risks of HRT in Breast Cancer Survivors?
An evolving understanding of the risks and benefits of HRT has led to a reevaluation of the role of HRT for breast cancer survivors.
bit.ly
April 3, 2026 at 11:40 PM
“PARPi may be approved in the mHSPC setting in the near future.” – @neerajagarwal.bsky.social at #ESMO25.

Ongoing trials could expand the reach of precision therapy beyond mCRPC

#ProstateCancer #Oncology #OncTwitter #MedEd #MedX #mPC #mHSPC
October 20, 2025 at 7:39 AM